Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass.
This prospective study of 36 adult patients undergoing cardiopulmonary bypass (CPB) was conducted to determine the utility of thromboelastography (TEG) versus platelet studies (bleeding time, platelet count, mean platelet volume) and standard coagulation tests (prothrombin time, activated partial thromboplastin time, fibrinogen) to more effectively discriminate patients likely to benefit from platelet or fresh frozen plasma (FFP) transfusion. Although the sensitivities of the bleeding time (71.4%) and platelet count (100%) were similar to the TEG (71.4%), the specificity (89.3%) of the TEG was greater than that of the bleeding time (78.5%) and platelet count (53.6%). Seven patients experienced clinically significant hemorrhage; 5 (71.4%) had an abnormal TEG. Three of 8 (38%) other patients with an abnormal TEG had no abnormal bleeding. Only 2 of 27 (7.4%) patients with a normal TEG had abnormal bleeding requiring platelet or FFP transfusion. Therefore, it is suggested that post-CPB patients with a normal TEG should not receive platelet or FFP transfusions empirically. If excessive bleeding is noted in a patient with a normal TEG, this suggests a surgically correctable etiology. Data from this series suggest that patients displaying an abnormal TEG appear to be at increased risk for hemorrhage; therefore, appropriate blood product support should be initiated at the first sign of accelerated bleeding.
Essell
J H
JH
Department of Hematology-Medical Oncology Service, Wilford Hall USAF Medical Center, Lackland AFB, TX 78236-5300.
Martin
T J
TJ
Salinas
J
J
Thompson
J M
JM
Smith
V C
VC
D000293:Adolescent; D000328:Adult; D000368:Aged; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000166:cytology; D001803:Blood Transfusion; D002315:Cardiopulmonary Bypass; D005340:Fibrinogen / Q000032:analysis; D005544:Forecasting; D006470:Hemorrhage / Q000097:blood / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D010949:Plasma; D010976:Platelet Count; D017713:Platelet Transfusion; D011446:Prospective Studies; D011517:Prothrombin Time; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013916:Thrombelastography
D005340:Fibrinogen